Clinical Trials Logo

Clinical Trial Summary

The purpose of this pilot study is to determine if washing out the bladder with large volumes of saline after surgical removal of bladder tumors helps to decrease the number of loose cells floating within the bladder after surgery. Anticipated decrease in tumor recurrence and/or progression rates will be measured.


Clinical Trial Description

Bladder tumor recurrence after resection of non-muscle invasive bladder cancer (NMIBC) occurs in 50-70% of patients despite the use of adjuvant anticancer therapy after surgery. This is a single-arm, non-randomized pilot study looking to determine whether post-Transurethral Resection of Bladder Tumor (TURBT) cells counts differ significantly between continuous washout of the bladder (CBI) with normal saline compared to pre-CBI wash out. Anticipated decrease in tumor recurrence and/or progression rates will also be measured, and each participant will act as their own internal control. ;


Study Design


Related Conditions & MeSH terms


NCT number NCT03839472
Study type Interventional
Source Case Comprehensive Cancer Center
Contact
Status Withdrawn
Phase N/A
Start date September 1, 2019
Completion date December 2022

See also
  Status Clinical Trial Phase
Completed NCT03672240 - Study of APL-1202 in Non-Muscle Invasive Bladder Cancer Patients Who Are Resistant to One Induction Course of BCG Treatment Phase 1/Phase 2
Recruiting NCT04179162 - Bacillus Calmette-Guérin (BCG) and Gemcitabine in People With High-Grade Non-Muscle Invasive Bladder Cancer That Came Back After BCG Treatment Phase 1/Phase 2
Terminated NCT03719300 - Codex: Study of Inodiftagene Vixteplasmid (BC-819) in Unresponsive NMIBC Phase 2
Terminated NCT03167151 - Pembrolizumab in Intermediate Risk Recurrent Non-muscle Invasive Bladder Cancer (NMIBC) Phase 1/Phase 2
Recruiting NCT03148158 - Assessment Of Bladder Tumors Stage And Grade By Outpatient Flexible Cystoscopy Performed By Urology Resident N/A
Terminated NCT06069453 - Hyaluronic Acid Sodium Salt and Hydeal-D in the Management of LUTS After TURBT for NMIBC. N/A
Completed NCT02009332 - Phase 1/2 Study of ABI-009 in Nonmuscle Invasive Bladder Cancer Phase 1/Phase 2
Recruiting NCT05176145 - Demonstration of the Medical Interest of the VisioCyt® Artificial Intelligence Test N/A